Alembic Pharmaceuticals Ltd receives EIR from USFDA for Injectable Facility at Karkhadi

Alembic Pharmaceuticals Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at our Injectable Facility (F-3) at Karkhadi from 18th August, 2022 to 30th August, 2022. This was a pre-approval inspection for ANDAs filed with the USFDA. The Company has already started receiving ANDA approvals manufactured at this facility.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 514.45 as compared to the previous close of Rs. 501.95. The total number of shares traded during the day was 8452 in over 892 trades.

The stock hit an intraday high of Rs. 523.25 and intraday low of 503.50. The net turnover during the day was Rs. 4311711.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 USFDA EIR InjectableFacility Karkhadi